一名鼻咽癌患者对顺铂过敏反应后成功脱敏。
Successful desensitization after hypersensitivity reaction to cisplatin in a patient with nasopharyngeal carcinoma.
作者信息
Kinouchi Arisa, Ishii Hiroki, Sakamoto Kaname, Sakurai Daiju
机构信息
Department of Otolaryngology, Head and Neck Surgery, Interdisciplinary Graduate School of Medical Science University of Yamanashi Chuo Japan.
出版信息
Clin Case Rep. 2022 Oct 22;10(10):e6444. doi: 10.1002/ccr3.6444. eCollection 2022 Oct.
Abstract
Hypersensitivity reaction to cisplatin can result in discontinuation of chemoradiotherapy in patients with head and neck squamous cell carcinoma. We describe a patient with nasopharyngeal carcinoma who developed cisplatin hypersensitivity and was successfully treated with cisplatin desensitization. Furthermore, it had little impact on the therapeutic performance of cisplatin-combined chemoradiotherapy.
摘要
顺铂过敏反应可导致头颈部鳞状细胞癌患者放化疗中断。我们描述了一名鼻咽癌患者，该患者出现了顺铂过敏反应，并通过顺铂脱敏治疗成功治愈。此外，这对顺铂联合放化疗的治疗效果影响很小。
相似文献
1
Successful desensitization after hypersensitivity reaction to cisplatin in a patient with nasopharyngeal carcinoma.
Clin Case Rep. 2022 Oct 22;10(10):e6444. doi: 10.1002/ccr3.6444. eCollection 2022 Oct.
2
Real-world evidence of cisplatin versus carboplatin in patients with locally advanced nasopharyngeal carcinoma receiving concurrent chemoradiotherapy: A multicenter analysis.
Asia Pac J Clin Oncol. 2023 Feb;19(1):51-61. doi: 10.1111/ajco.13668. Epub 2022 Apr 8.
3
Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma.
Int J Clin Oncol. 2024 Jan;29(1):20-26. doi: 10.1007/s10147-023-02423-w. Epub 2023 Oct 16.
4
Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
Jpn J Clin Oncol. 2015 Dec;45(12):1116-21. doi: 10.1093/jjco/hyv142. Epub 2015 Sep 29.
5
Definitive chemoradiotherapy with carboplatin for squamous cell carcinoma of the head and neck.
Laryngoscope. 2017 Oct;127(10):2260-2264. doi: 10.1002/lary.26554. Epub 2017 Mar 8.
6
TPF plus cetuximab induction chemotherapy followed by biochemoradiation with weekly cetuximab plus weekly cisplatin or carboplatin: a randomized phase II EORTC trial.
Ann Oncol. 2017 Sep 1;28(9):2219-2224. doi: 10.1093/annonc/mdx300.
7
Desensitization treatment with cisplatin after carboplatin hypersensitivity reaction in gynecologic cancer.
J Med Invest. 2010 Feb;57(1-2):163-7. doi: 10.2152/jmi.57.163.
8
Carboplatin/5-fluorouracil as an alternative to cisplatin/5- fluorouracil for metastatic and recurrent head and neck squamous cell carcinoma and nasopharyngeal carcinoma.
Asian Pac J Cancer Prev. 2013;14(2):1121-6. doi: 10.7314/apjcp.2013.14.2.1121.
9
[Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma].
Gan To Kagaku Ryoho. 2007 Sep;34(9):1505-8.
10
Cetuximab-Based vs Carboplatin-Based Chemoradiotherapy for Patients With Head and Neck Cancer.
JAMA Otolaryngol Head Neck Surg. 2022 Nov 1;148(11):1022-1028. doi: 10.1001/jamaoto.2022.2791.
本文引用的文献
1
Hypersensitivity Reactions to Platinum Agents and Taxanes.
Clin Rev Allergy Immunol. 2022 Jun;62(3):432-448. doi: 10.1007/s12016-021-08877-y. Epub 2021 Aug 2.
2
A clinical classification system for grading platinum hypersensitivity reactions.
Gynecol Oncol. 2020 Dec;159(3):794-798. doi: 10.1016/j.ygyno.2020.09.009. Epub 2020 Sep 18.
3
Allergy Evaluation of Hypersensitivity to Platinum Salts and Taxanes: A Six-Year Experience.
J Allergy Clin Immunol Pract. 2020 May;8(5):1658-1664. doi: 10.1016/j.jaip.2019.12.032. Epub 2020 Jan 7.
4
Platinum Chemotherapy Hypersensitivity: Prevalence and Management.
Immunol Allergy Clin North Am. 2017 Nov;37(4):663-677. doi: 10.1016/j.iac.2017.06.003. Epub 2017 Aug 19.
5
Presentation and Diagnosis of Hypersensitivity to Platinum Drugs.
Curr Allergy Asthma Rep. 2015 Apr;15(4):15. doi: 10.1007/s11882-015-0515-3.
6
An integrated view of cisplatin-induced nephrotoxicity and ototoxicity.
Toxicol Lett. 2015 Sep 17;237(3):219-27. doi: 10.1016/j.toxlet.2015.06.012. Epub 2015 Jun 20.
7
Platinum hypersensitivity and desensitization.
Jpn J Clin Oncol. 2015 Sep;45(9):795-804. doi: 10.1093/jjco/hyv081. Epub 2015 Jun 7.
8
4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.
Int J Clin Oncol. 2015 Jun;20(3):566-73. doi: 10.1007/s10147-014-0731-1. Epub 2014 Jul 18.
9
Diagnostic tools for hypersensitivity to platinum drugs and taxanes: skin testing, specific IgE, and mast cell/basophil mediators.
Curr Allergy Asthma Rep. 2014 Aug;14(8):451. doi: 10.1007/s11882-014-0451-7.
10
Carboplatin-, oxaliplatin-, and cisplatin-specific IgE: cross-reactivity and value in the diagnosis of carboplatin and oxaliplatin allergy.
J Allergy Clin Immunol Pract. 2013 Sep-Oct;1(5):494-500. doi: 10.1016/j.jaip.2013.06.002. Epub 2013 Aug 30.
Zotero 插件